Drugs Made In America Acquisition (DMII) Accumulated Expenses (2025 - 2026)
Drugs Made In America Acquisition (DMII) posted Accumulated Expenses of $69,159 for Q2 2026.
Powered by 
Analysis
Drugs Made In America Acquisition (DMII) Accumulated Expenses (2025 - 2026) Analysis & Trends
At the end of FY2025, Drugs Made In America Acquisition's Accumulated Expenses came in at $88,343.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | BlackRock | 164.13 Bn | 110.49 Bn | - |
| 2 | Spdr Gold Trust | 133.82 Bn | -424.18 Bn | - |
| 3 | Blackstone | 84.08 Bn | 79.01 Bn | - |
| 4 | Brookfield | 82.97 Bn | -82.41 Bn | 4.47 Bn |
| 5 | Kkr | 81.05 Bn | 47.53 Bn | - |
| 6 | Brookfield Asset Management | 71.64 Bn | 67.88 Bn | - |
| 7 | Apollo Global Management | 65.67 Bn | 3.35 Bn | 10.56 Bn |
| 8 | Wheaton Precious Metals | 61.89 Bn | 57.32 Bn | 687.86 Mn |
| 9 | Franco Nevada | 46.13 Bn | 43.49 Bn | 451.00 Mn |
| 10 | Drugs Made In America Acquisition | 649.10 Mn | 649.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69,159.00 |
| Dec 31, 2025 | 88,343.00 |
| Sep 30, 2025 | 5,843.00 |
API Access
Drugs Made In America Acquisition Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=DMII&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "DMII", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=DMII&period=max&api_key=YOUR_API_KEY");
const data = await res.json();